tiprankstipranks
Health Advance Inc (HADV)
OTHER OTC:HADV
US Market
HADV
Health Advance
RESEARCH TOOLSreports

Health Advance (HADV) Ratios

15 Followers

Health Advance Ratios

HADV's free cash flow for Q3 2026 was $0.00. For the 2026 fiscal year, HADV's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
 0.79 0.79 1.11 1.32 2.72
Quick Ratio
 0.79 0.79 1.11 1.32 2.72
Cash Ratio
 <0.01 <0.01 <0.01 0.03 0.03
Solvency Ratio
 -0.13 -0.13 -0.09 -0.20 0.35
Operating Cash Flow Ratio
 -0.14 -0.14 -0.04 -1.10 -4.20
Short-Term Operating Cash Flow Coverage
 -0.70 -0.70 -0.65 -18.97 -63.00
Net Current Asset Value
$ -365.22K$ -365.22K$ -223.63K$ -174.61K$ -154.96K
Leverage Ratios
Debt-to-Assets Ratio
 0.71 0.71 0.54 0.53 0.77
Debt-to-Equity Ratio
 -1.95 -1.95 -6.48 38.15 8.93
Debt-to-Capital Ratio
 2.06 2.06 1.18 0.97 0.90
Long-Term Debt-to-Capital Ratio
 2.95 2.95 1.20 0.97 0.90
Financial Leverage Ratio
 -2.75 -2.75 -11.94 72.38 11.57
Debt Service Coverage Ratio
 -0.63 -0.63 -2.52 -6.62 26.09
Interest Coverage Ratio
 -2.71 -2.71 -44.79 -312.62 -193.89
Debt to Market Cap
 11.10 0.85 0.38 0.31 0.03
Interest Debt Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
 -5.44 -5.44 -5.67 -2.58 2.41
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%100.00%
EBIT Margin
0.00%0.00%0.00%0.00%-1997.42%
EBITDA Margin
0.00%0.00%0.00%0.00%1512.87%
Operating Profit Margin
0.00%0.00%0.00%0.00%-1940.68%
Pretax Profit Margin
0.00%0.00%0.00%0.00%-2007.36%
Net Profit Margin
0.00%0.00%0.00%0.00%-2007.36%
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%-2007.36%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
133.32%133.32%103.05%101.24%103.44%
Return on Assets (ROA)
-17.29%-17.29%-9.78%-52.94%-42.30%
Return on Equity (ROE)
55.38%47.51%116.77%-3831.39%-489.49%
Return on Capital Employed (ROCE)
-69.63%-69.63%-22.43%-102.00%-48.21%
Return on Invested Capital (ROIC)
-37.62%-37.62%-20.68%-96.67%-47.64%
Return on Tangible Assets
-26.87%-26.87%-15.26%-81.87%-101.39%
Earnings Yield
-34.16%-20.70%-6.82%-31.53%-1.62%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 0.00 0.18
Payables Turnover
 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 3.95
Asset Turnover
 0.00 0.00 0.00 0.00 0.02
Working Capital Turnover Ratio
 0.00 0.00 0.00 0.00 0.14
Cash Conversion Cycle
 0.00 0.00 0.00 0.00 2.03K
Days of Sales Outstanding
 0.00 0.00 0.00 0.00 2.03K
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 0.00 0.00 0.00 0.00 0.00
Operating Cycle
 0.00 0.00 0.00 0.00 2.03K
Cash Flow Ratios
Operating Cash Flow Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Free Cash Flow Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
CapEx Per Share
 0.00 0.00 0.00 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 0.00 0.00 0.00 -85.92K -47.87K
Capital Expenditure Coverage Ratio
 0.00 0.00 0.00 -85.92K -47.87K
Operating Cash Flow Coverage Ratio
 -0.16 -0.16 -0.04 -1.02 -0.83
Operating Cash Flow to Sales Ratio
 0.00 0.00 0.00 0.00 -30.23
Free Cash Flow Yield
-174.56%-13.34%-1.62%-31.94%-2.45%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -2.93 -4.83 -12.88 -3.07 -62.50
Price-to-Sales (P/S) Ratio
 0.00 0.00 0.00 0.00 1.24K
Price-to-Book (P/B) Ratio
 -1.39 -2.29 -17.12 121.53 301.48
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.57 -7.50 -61.68 -3.13 -40.90
Price-to-Operating Cash Flow Ratio
 -4.54 -7.50 -61.68 -3.13 -40.90
Price-to-Earnings Growth (PEG) Ratio
 -0.03 0.00 0.16 -0.04 0.07
Price-to-Fair Value
 -1.39 -2.29 -17.12 121.53 301.48
Enterprise Value Multiple
 -5.94 -11.89 -20.65 -11.05 84.13
Enterprise Value
 388.36K 777.46K 990.43K 1.12M 8.28M
EV to EBITDA
 -5.94 -11.89 -20.65 -11.05 84.13
EV to Sales
 0.00 0.00 0.00 0.00 1.27K
EV to Free Cash Flow
 -6.91 -13.84 -85.00 -4.08 -42.10
EV to Operating Cash Flow
 -6.91 -13.84 -85.00 -4.08 -42.10
Tangible Book Value Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Shareholders’ Equity Per Share
 >-0.01 >-0.01 >-0.01 <0.01 <0.01
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.00 0.00 0.00 0.00 <0.01
Net Income Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.33 1.33 1.02 1.00 1.00
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.00 0.00 0.00 0.00 20.41
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.64 0.64 0.24 1.01 1.51
Currency in USD